Merck & Co. Inc, Akorn deal

InSite Vision Inc. (OTCBB:INSV, Alameda, Calif.) settled a lawsuit against Mylan N.V. (NASDAQ:MYL, Canonsburg, Pa.) concerning Mylan’s ANDA for 1% azithromycin ophthalmic solution. The settlement triggers an increase to 9% from 8% in the royalty rate paid to InSite from Akorn on net sales of AzaSite of less than $20 million. Other royalty terms remain the same. ...